EL7.AI
StocksMedium•23 October 2026•
3 min read

Balchem’s Adjusted Earnings Reach $1.57 per Share and Revenue $290.7 Million in Q3

Key Facts

1Adjusted earnings per share were $1.57 in the third quarter of 2026, beating estimates by $0.04.
2Revenue reached $290.7 million, $1.45 million above estimates.
3In the second quarter, the company reported net sales of $284.0 million, net income of $44.6 million and adjusted EBITDA of $77.9 million.
4Balchem scheduled the release of its third-quarter results before the market opened on October 23, 2026.

A Seeking Alpha summary reported that Balchem posted adjusted earnings of $1.57 per share and revenue of $290.7 million in the third quarter of 2026, beating earnings and revenue estimates. Earnings per share exceeded estimates by $0.04, while revenue topped estimates by $1.45 million. The company had scheduled the release of its results before the market opened on October 23, 2026. The figures come as markets track the company’s ability to sustain growth, following a series of quarters in which adjusted EBITDA rose year over year. Beating both key measures gives the third-quarter results a stronger start than analysts had expected ahead of the release.

An Investing.com article attributed to Reuters estimated earnings per share at $1.43 and revenue at $289.25 million for the quarter ended in September. Balchem’s actual earnings reported in the Seeking Alpha summary therefore beat the estimate by $0.04, while revenue came in $1.45 million higher than forecast. The same article said the company entered the third quarter after 28 consecutive quarters of year-over-year growth in adjusted EBITDA. That streak underscores the results’ importance to investors, as continued growth in operating earnings remains a focus in assessing the company’s performance. However, the available results summary does not provide the third-quarter growth rate or segment performance details, so a year-over-year comparison for the new results is unavailable.

In the second quarter of 2026, Balchem reported net sales of $284.0 million, net income of $44.6 million and adjusted EBITDA of $77.9 million, according to a company statement. Adjusted earnings per share were $1.49, compared with $1.27 in the second quarter of 2025. Net sales rose 11.2% year over year in the quarter, while GAAP net income increased 16.6%. CEO Ted Harris said the second quarter was “another strong quarter for Balchem, with healthy growth across our three segments.” Those results offer a recent reference point for the company’s business scale and profitability ahead of the third-quarter figures.

Balchem had scheduled a quarterly call to review its third-quarter results for October 23 at 11:00 a.m. Eastern Time, hosted by the CEO and CFO. The call was set for the same day the company said it would release results before the market opened. It gives management an opportunity to present and discuss the results with investors after their release. The call follows the second-quarter performance, which the CEO described at the time as strong, with growth across all three segments. The company’s shares closed at $173.23 on October 22, according to the data provided.